The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection of following Fomula (I). Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
申请公布号
CA2835688(A1)
申请公布日期
2012.11.15
申请号
CA20122835688
申请日期
2012.05.09
申请人
BRISTOL-MYERS SQUIBB COMPANY
发明人
CHEN, QI;LOPEZ, OMAR D.;BENDER, JOHN A.;WANG, GAN;NGUYEN, VAN N.;KADOW, JOHN F.;MEANWELL, NICHOLAS A.;BELEMA, MAKONEN